|Dr.Ferzaan Engineer-Chairman addressing media.|
India,announced the closure of its $31 million series A round,including
participation from Goldman Sachs ,a leading global investment bank &
active investor in India.The investment will be used towards a long term
growth strategy focused on establishing an oncology franchise across four
to five cities throughout India.
Cytecare launched its 150 bed hospital in Bengaluru in November,2016.
Addressing media,Mr.Suresh Ramu,CEO,said,"the hospital made difference
for 5000 lives,of which 4000 are Indian & 1000,foreign patients.He said the
hospital will invest about Rs.700 crores in 4 to 5 years and target revenues
of about Rs.1000 crores in 7 to 8 years.".
Dr.Ferzaan Engineer,Chairman & Co Founder said that Cancer is curable
if detected early & Cancer is not one disease but a family of diseases.Though
they have no immediate plans to go for an IPO,it is not ruled out,he said.